Related Experiment Video
Updated: Nov 30, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.3K
Syringotropic Melanoma: A Diagnostic Challenge With Prognostic Implications
Juan Torre-Castro1, Lara Haya-Martínez1, Cristina Moya-Martínez1
1Departments Dermatology and.
The American Journal of Dermatopathology
|November 17, 2020
Summary
Syringotropic melanoma, a rare skin cancer variant, involves neoplastic melanocytes in eccrine structures. This study presents new cases and reviews literature to clarify its origin, staging, and prognosis.
Area of Science:
- Dermatopathology
- Oncology
- Melanoma Research
Background:
- Syringotropic melanoma is an exceptionally rare variant of cutaneous melanoma.
- Neoplastic melanocytes are found within the eccrine apparatus, extending into the dermis and subcutaneous tissue.
- The biological behavior, staging, and origin of syringotropic melanoma remain poorly understood and debated.
Purpose of the Study:
- To present six new cases of syringotropic melanoma.
- To detail the key histopathologic features of these cases.
- To review existing literature and discuss the controversial aspects of syringotropic melanoma, including its origin, staging, and prognosis.
Main Methods:
- Case series presentation of six patients diagnosed with syringotropic melanoma.
- Detailed histopathologic examination of all reported cases.
- Comprehensive literature review and synthesis of current knowledge regarding syringotropic melanoma.
Main Results:
- Six new cases of syringotropic melanoma were identified and characterized.
- Histopathologic features relevant to diagnosis and classification were documented.
- The review highlighted the rarity and controversial nature of syringotropic melanoma's behavior and staging.
Conclusions:
- Syringotropic melanoma is a rare entity with unique histopathologic findings.
- Further research is needed to establish standardized staging and understand the biological behavior.
- Clarifying the origin and prognosis is crucial for effective patient management.

